Steven Batki, MD
Professor
Psychiatry
School of Medicine

Dr. Batki is engaged in addiction research, training, and clinical services.

Dr. Batki’s research and clinical interests include pharmacologic treatment for addiction to alcohol, opioids, and stimulants. His work focuses on psychiatric and medical disorders that co-occur with addiction, such as such as PTSD, traumatic brain injury (TBI), schizophrenia, and HIV/HCV. He has published extensively on clinical research in addiction and co-occurring disorders. He chaired the SAMSHA CSAT Treatment Improvement Protocol No. 37, Substance Abuse Treatment for Persons with HIV/AIDS, and Treatment Improvement Protocol No. 43, Medication-Assisted Treatment for Opioid Dependence.

Dr. Batki's current research is supported by the Department of Defense and NIDA. His DoD projects are examining the effectiveness of pharmacotherapy for alcohol use disorders in veterans with posttraumatic stress disorder (PTSD) as well as in veterans with mild traumatic brain injury (TBI). Dr. Batki is also conducting NIDA-funded research on the pharmacotherapy of methamphetamine dependence. Recently completed NIDA and NIAAA work has included the study of hepatitis C treatment in injection drug users and the pharmacological treatment of alcohol dependence in schizophrenia.

• Impact of Alcohol Use, Traumatic Stress, and Cigarette Smoking on Cognitive Functioning in Veterans With Co-occurring Alcohol Use Disorder and Posttraumatic Stress Disorder.
  Military medicine 2022 Hua JPY, Cano M, Batki SL, Pennington DL
• Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
  JAMA 2022 Oslin DW, Lynch KG, Shih MC, Ingram EP, Wray LO, Chapman SR, Kranzler HR, Gelernter J, Pyne JM, Stone A, DuVall SL, Lehmann LS, Thase ME, PRIME Care Research Group, Aslam M, Batki SL, Bjork JM, Blow …
• The Impact of Exercise and Virtual Reality Executive Function Training on Cognition Among Heavy Drinking Veterans With Traumatic Brain Injury: A Pilot Feasibility Study.
  Frontiers in behavioral neuroscience 2022 Pennington DL, Reavis JV, Cano MT, Walker E, Batki SL
• Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial.
  Frontiers in psychiatry 2022 Stauffer CS, Samson S, Hickok A, Hoffman WF, Batki SL
• Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial.
  PloS one 2021 Santos GM, Ikeda J, Coffin P, Walker JE, Matheson T, McLaughlin M, Jain J, Vittinghoff E, Batki SL
• Working memory and alcohol demand relationships differ according to PTSD symptom severity among veterans with AUD.
  Experimental and clinical psychopharmacology 2021 Abram SV, Batki SL, Pennington DL
• Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial.
  Sleep 2020 Neylan TC, Richards A, Metzler TJ, Ruoff LM, Varbel J, O'Donovan A, Sivasubramanian M, Motraghi T, Hlavin J, Batki SL, Inslicht SS, Samuelson K, Morairty SR, Kilduff TS
• A randomized pilot trial of topiramate for alcohol use disorder in veterans with traumatic brain injury: Effects on alcohol use, cognition, and post-concussive symptoms.
  Drug and alcohol dependence 2020 Pennington DL, Bielenberg J, Lasher B, Herbst E, Abrams G, Novakovic-Agopian T, Batki SL
• Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.
  JAMA psychiatry 2020 Coffin PO, Santos GM, Hern J, Vittinghoff E, Walker JE, Matheson T, Santos D, Colfax G, Batki SL
• Care of the Transgender Patient.
  Annals of internal medicine 2019 Herbst ED, Harris E, Pennington DL, Batki SL
• Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial.
  Alcoholism, clinical and experimental research 2019 Stauffer CS, Meinzer NK, Morrison T, Wen JH, Radanovich L, Leung D, Niles A, O'Donovan A, Batki SL, Woolley JD
• An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines.
  Substance abuse 2018 Zaman T, Rife TL, Batki SL, Pennington DL
• Mobile Technology for Treatment Augmentation in Veteran Smokers With Posttraumatic Stress Disorder.
  American journal of preventive medicine 2017 Herbst E, Pennington D, Kuhn E, McCaslin SE, Delucchi K, Batki SL, Dickter B, Carmody T
• Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.
  Addiction (Abingdon, England) 2017 Coffin PO, Santos GM, Hern J, Vittinghoff E, Santos D, Matheson T, Colfax G, Batki SL
• Race/ethnicity, education, and age are associated with engagement in ecological momentary assessment text messaging among substance-using MSM in San Francisco.
  Journal of substance abuse treatment 2017 Turner CM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Batki S, Santos GM
• Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder.
  The Journal of clinical psychiatry 2016 Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC
• Relations Between Cognitive Functioning and Alcohol Use, Craving, and Post-Traumatic Stress: An Examination Among Trauma-Exposed Military Veterans With Alcohol Use Disorder.
  Military medicine 2016 Heinz AJ, Pennington DL, Cohen N, Schmeling B, Lasher BA, Schrodek E, Batki SL
• The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.
  Psychopharmacology 2016 Woolley JD, Arcuni PA, Stauffer CS, Fulford D, Carson DS, Batki S, Vinogradov S
• Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men.
  Journal of acquired immune deficiency syndromes (1999) 2016 Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL
• What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?
  The Journal of clinical psychiatry 2015 Batki SL
• Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.
  Journal of psychiatric research 2015 Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH
• Behavioral treatment of insomnia in early recovery.
  Journal of addiction medicine 2014 Kaplan KA, McQuaid J, Batki SL, Rosenlicht N
• A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder.
  Psychiatry research 2014 Pennington DL, Abé C, Batki SL, Meyerhoff DJ
• Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.
  Alcoholism, clinical and experimental research 2014 Batki SL, Pennington DL, Lasher B, Neylan TC, Metzler T, Waldrop A, Delucchi K, Herbst E
• Cognitive-behavioral therapy in depressed primary care patients with co-occurring problematic alcohol use: effect of telephone-administered vs. face-to-face treatment-a secondary analysis.
  Journal of psychoactive drugs 2014 Kalapatapu RK, Ho J, Cai X, Vinogradov S, Batki SL, Mohr DC
• Toward personalized medicine in the pharmacotherapy of alcohol use disorder: targeting patient genes and patient goals.
  The American journal of psychiatry 2014 Batki SL, Pennington DL
• Alcohol use biomarkers predicting cognitive performance: a secondary analysis in veterans with alcohol dependence and posttraumatic stress disorder.
  Military medicine 2013 Kalapatapu RK, Delucchi KL, Lasher BA, Vinogradov S, Batki SL
• Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
  Journal of clinical psychopharmacology 2013 Meszaros ZS, Abdul-Malak Y, Dimmock JA, Wang D, Ajagbe TO, Batki SL
• Relationship of age to impulsivity and decision making: a baseline secondary analysis of a behavioral treatment study in stimulant use disorders.
  Journal of addictive diseases 2013 Kalapatapu RK, Lewis DF, Vinogradov S, Batki SL, Winhusen T
• Team-based learning exercise efficiently teaches brief intervention skills to medicine residents.
  Substance abuse 2013 Wamsley MA, Julian KA, O'Sullivan P, McCance-Katz EF, Batki SL, Satre DD, Satterfield J
• Using standardized patients to evaluate screening, brief intervention, and referral to treatment (SBIRT) knowledge and skill acquisition for internal medicine residents.
  Substance abuse 2012 Satterfield JM, O'Sullivan P, Satre DD, Tsoh JY, Batki SL, Julian K, McCance-Katz EF, Wamsley M
• Accuracy of self-reported medical problems in patients with alcohol dependence and co-occurring schizophrenia or schizoaffective disorder.
  Schizophrenia research 2011 Meszaros ZS, Dimmock JA, Ploutz-Snyder R, Chauhan SV, Abdul-Malak Y, Middleton FA, Batki SL
• Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.
  The American journal on addictions 2011 Meszaros ZS, Dimmock JA, Ploutz-Snyder RJ, Abdul-Malak Y, Leontieva L, Canfield K, Batki SL
• Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment.
  The American journal on addictions 2011 Batki SL, Canfield KM, Ploutz-Snyder R
• Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control study.
  Journal of addictive diseases 2010 Batki SL, Canfield KM, Smyth E, Ploutz-Snyder R, Levine RA
• Pharmacological approaches to methamphetamine dependence: a focused review.
  British journal of clinical pharmacology 2010 Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL
• The description and evaluation of the implementation of an integrated healthcare model.
  Families, systems & health : the journal of collaborative family healthcare 2010 Funderburk JS, Sugarman DE, Maisto SA, Ouimette P, Schohn M, Lantinga L, Wray L, Batki S, Nelson B, Coolhart D, Strutynski K
• Pregabalin treatment of anxiety in patients with substance use disorders.
  The Annals of pharmacotherapy 2010 Raza S, Siddiqui UA, Megna JL, Schwartz TL, Batki SL
• Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.
  Substance use & misuse 2010 Canfield KM, Smyth E, Batki SL
• Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
  Drug and alcohol dependence 2009 Batki SL, Canfield KM, Smyth E, Ploutz-Snyder R
• Patient and provider attitudes towards monitored naltrexone treatment of alcohol dependence in schizophrenia.
  The American journal of drug and alcohol abuse 2009 Leontieva L, Dimmock J, Cavallerano M, DeRycke S, Meszaros Z, Carey K, Ploutz-Snyder R, Batki SL
• Medical comorbidity in patients with schizophrenia and alcohol dependence.
  Schizophrenia research 2008 Batki SL, Meszaros ZS, Strutynski K, Dimmock JA, Leontieva L, Ploutz-Snyder R, Canfield K, Drayer RA
• Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.
  Schizophrenia research 2008 Batki SL, Leontieva L, Dimmock JA, Ploutz-Snyder R
• A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.
  Drug and alcohol dependence 2008 Gruber VA, Delucchi KL, Kielstein A, Batki SL
• Voucher-based incentives for naltrexone treatment attendance in schizophrenia and alcohol use disorders.
  Psychiatric services (Washington, D.C.) 2008 Leontieva L, Dimmock JA, Gately PW, Gallinger L, Ploutz-Snyder R, Batki SL
• Pharmacological treatment of schizophrenia and co-occurring substance use disorders.
  CNS drugs 2008 Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R
• Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia-spectrum disorders.
  The American journal on addictions 2007 Batki SL, Dimmock JA, Wade M, Gately PW, Cornell M, Maisto SA, Carey KB, Ploutz-Snyder R
• Adapting Motivational Interventions for Comorbid Schizophrenia and Alcohol Use Disorders.
  Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association 2007 Carey KB, Leontieva L, Dimmock J, Maisto SA, Batki SL
• Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.
  Drug and alcohol dependence 2006 Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S
• Lamotrigine-associated rash and blood dyscrasias in a methadone-treatment patient with hepatitis C.
  Psychosomatics 2006 Alleyne S, Alao A, Batki SL
• Rural jail telepsychiatry: a pilot feasibility study.
  Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2005 Manfredi L, Shupe J, Batki SL
• Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.
  Journal of psychiatric practice 2005 Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD
• Fluoxetine attenuates adrenocortical but not subjective responses to cocaine cues.
  The American journal of drug and alcohol abuse 2004 Harris DS, Batki SL, Berger SP
• Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia.
  The American journal on addictions 2004 Batki SL, Harris DS
• Comorbidity of bipolar disorder and substance abuse in Costa Rica: pedigree- and population-based studies.
  Journal of affective disorders 2002 Escamilla MA, Batki S, Reus VI, Spesny M, Molina J, Service S, Vinogradov S, Neylan T, Mathews C, Meza L, Gallegos A, Montero AP, Cruz ML, Neuhaus J, Roche E, Smith L, Leon P, Freimer NB
• Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate.
  American journal of human genetics 2002 Ophoff RA, Escamilla MA, Service SK, Spesny M, Meshi DB, Poon W, Molina J, Fournier E, Gallegos A, Mathews C, Neylan T, Batki SL, Roche E, Ramirez M, Silva S, De Mille MC, Dong P, Leon PE, Reus VI, …
• A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.
  Drug and alcohol dependence 2002 Batki SL, Gruber VA, Bradley JM, Bradley M, Delucchi K
• Medical service use and financial charges among opioid users at a public hospital.
  Drug and alcohol dependence 2002 Masson CL, Sorensen JL, Batki SL, Okin R, Delucchi KL, Perlman DC
• Urine toxicology samples in cocaine treatment trials: how many need to be tested?
  Journal of addictive diseases 2002 Delucchi KL, Batki SL, Moon J, Jacob P, Jones RT
• Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population.
  Proceedings of the National Academy of Sciences of the United States of America 2001 McInnes LA, Service SK, Reus VI, Barnes G, Charlat O, Jawahar S, Lewitzky S, Yang Q, Duong Q, Spesny M, Araya C, Araya X, Gallegos A, Meza L, Molina J, Ramirez R, Mendez R, Silva S, Fournier E, Batki …
• Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18.
  American journal of medical genetics 2001 Escamilla MA, McInnes LA, Service SK, Spesny M, Reus VI, Molina J, Gallegos A, Fournier E, Batki S, Neylan T, Matthews C, Vinogradov S, Roche E, Tyler DJ, Shimayoshi N, Mendez R, Ramirez R, Ramirez M,…
• Utility of routine drug screening in a psychiatric emergency setting.
  Psychiatric services (Washington, D.C.) 2000 Schiller MJ, Shumway M, Batki SL
• Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis.
  Annals of the New York Academy of Sciences 2000 Batki SL, Moon J, Delucchi K, Bradley M, Hersh D, Smolar S, Mengis M, Lefkowitz E, Sexe D, Morello L, Everhart T, Jones RT, Jacob P
• Patterns of substance use among patients in an urban psychiatric emergency service.
  Psychiatric services (Washington, D.C.) 2000 Schiller MJ, Shumway M, Batki SL
• Stimulant psychosis: symptom profile and acute clinical course.
  The American journal on addictions 2000 Harris D, Batki SL
• Substance abuse and HIV infection.
  New directions for mental health services 2000 Ferrando SJ, Batki SL
• Sulfonium salts as derivatizing agents. 3. Quantitation of the cocaine metabolite benzoylecgonine in urine using gas chromatography with ion-pair extraction/on-column alkylation.
  Journal of analytical toxicology 1999 Panganiban K, Jacob P, Everhart ET, Tisdale EC, Batki SL, Mendelson JE, Jones RT
• Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18.
  American journal of human genetics 1999 Escamilla MA, McInnes LA, Spesny M, Reus VI, Service SK, Shimayoshi N, Tyler DJ, Silva S, Molina J, Gallegos A, Meza L, Cruz ML, Batki S, Vinogradov S, Neylan T, Nguyen JB, Fournier E, Araya C, …
• Medication adherence strategies for drug abusers with HIV/AIDS.
  AIDS care 1998 Sorensen JL, Mascovich A, Wall TL, DePhilippis D, Batki SL, Chesney M
• Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.
  Addiction (Abingdon, England) 1998 Ling W, Charuvastra C, Collins JF, Batki S, Brown LS, Kintaudi P, Wesson DR, McNicholas L, Tusel DJ, Malkerneker U, Renner JA, Santos E, Casadonte P, Fye C, Stine S, Wang RI, Segal D
• Buprenorphine and naloxone interactions in methadone maintenance patients.
  Biological psychiatry 1997 Mendelson J, Jones RT, Welm S, Brown J, Batki SL
• Measurement properties of quantitative urine benzoylecgonine in clinical trials research.
  Addiction (Abingdon, England) 1997 Delucchi KL, Jones RT, Batki SL
• A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees.
  Proceedings of the National Academy of Sciences of the United States of America 1996 McInnes LA, Escamilla MA, Service SK, Reus VI, Leon P, Silva S, Rojas E, Spesny M, Baharloo S, Blankenship K, Peterson A, Tyler D, Shimayoshi N, Tobey C, Batki S, Vinogradov S, Meza L, Gallegos A, …
• Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease.
  The American journal of drug and alcohol abuse 1996 Ferrando SJ, Wall TL, Batki SL, Sorensen JL
• A controlled trial of fluoxetine in crack cocaine dependence.
  Drug and alcohol dependence 1996 Batki SL, Washburn AM, Delucchi K, Jones RT
• An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees.
  American journal of medical genetics 1996 Freimer NB, Reus VI, Escamilla M, Spesny M, Smith L, Service S, Gallegos A, Meza L, Batki S, Vinogradov S, Leon P, Sandkuijl LA
• Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23.
  Nature genetics 1996 Freimer NB, Reus VI, Escamilla MA, McInnes LA, Spesny M, Leon P, Service SK, Smith LB, Silva S, Rojas E, Gallegos A, Meza L, Fournier E, Baharloo S, Blankenship K, Tyler DJ, Batki S, Vinogradov S, …
• Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits.
  Psychiatric services (Washington, D.C.) 1996 Herbst MD, Batki SL, Manfredi LB, Jones T
• Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care.
  Drug and alcohol dependence 1995 Wall TL, Sorensen JL, Batki SL, Delucchi KL, London JA, Chesney MA
• Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
  Journal of clinical psychopharmacology 1993 Batki SL, Manfredi LB, Jacob P, Jones RT
• HIV-infected intravenous drug users in methadone maintenance treatment: clinical problems and their management.
  Journal of psychoactive drugs 1991 Ferrando SJ, Batki SL
• Buspirone in drug users with AIDS or AIDS-related complex.
  Journal of clinical psychopharmacology 1990 Batki SL
• Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis.
  The Western journal of medicine 1990 Batki SL
• Fluoxetine for cocaine abuse in methadone patients: preliminary findings.
  NIDA research monograph 1990 Batki SL, Manfredi LB, Sorensen JL, Jacob P, Dumontet R, Jones RT
• Substance abuse and AIDS: the need for mental health services.
  New directions for mental health services 1990 Batki SL
• Changes in needle sharing and syringe cleaning among San Francisco drug abusers.
  The New England journal of medicine 1989 Sorensen JL, Guydish J, Costantini M, Batki SL
• HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report.
  NIDA research monograph 1989 Batki SL, Sorensen JL, Gibson DR, Maude-Griffin P
• Methadone maintenance program for AIDS-affected opiate addicts.
  Journal of substance abuse treatment 1989 Sorensen JL, Batki SL, Good P, Wilkinson K
• Psychiatric aspects of treatment of i.v. drug abusers with AIDS.
  Hospital & community psychiatry 1988 Batki SL, Sorensen JL, Faltz B, Madover S
• Treatment of intravenous drug users with AIDS: the role of methadone maintenance.
  Journal of psychoactive drugs 1988 Batki SL
• Psychiatric and ethical issues in the care of patients with AIDS.
  Psychosomatics 1986 Dilley JW, Shelp EE, Batki SL